REV: Responsibly and reliably powering industry
With a focus on the creation of innovative technology and forward-thinking practical solutions, REV offers flexible, durable, reliable
Kramer Mazda: The largest Mazda dealership in Western Canada
The largest Mazda dealership in Calgary and Western Canada, for over 40 years Kramer Mazda has been developing
German-Canadian Care Home: An innovative new vision for elder care
Providing compassionate care to seniors in Vancouver for over 50 years, the German-Canadian Care Home is part of
Hinton Scaffold Solutions: Utilizing innovate technologies to create safer worksites
With many years of experience in the heavy industrial scaffold industry, Ontario-based Hinton Scaffold Solutions provides highly innovative
Alberta Veterinary Laboratories / Solvet: Supporting Canada’s food
Founded in 2009, Western Canadian family-owned pharmaceutical manufacturer Alberta Veterinary Laboratories manufactures and provides efficacious and cost-effective animal
Sodexo Canada: The global leader who believes the difference a day makes
Founded in Marseille in 1966, and now operating in 53 countries, Sodexo provides facilities services that drive positive
Barclay Restorations DKI: The longest running insurance restoration company in Greater Vancouver
Locally owned-and operated and serving Metro Vancouver and the Fraser Valley, Barclay Restorations DKI is a full-service restoration
CDW Canada: Helping small businesses use IT security to prepare, defend, and respond
Established in 2003, CDW Canada is a leading provider of technology solutions for business, government, education, and healthcare,
Taiwan: key to win-win approach for Canadian Industry
Taiwan’s innovation leadership and significant economic potential in Asia is an opportunity for Canada to stay competitive on
Taking charitable giving to the next level
Empowering employees to support the causes that matter most to them is the best way to maximize charitable
Lots of money seeking company acquisitions – The case of private equity
At this time, there is more money in the system than anyone can imagine. It is estimated that
There’s optimism amid instability in the Canadian construction landscape
The last year has been among the most expensive on record for many Canadians. Families and those on
Washed up elites need to stop lecturing the people
The ramblings of ex-Prime Ministers, Presidents and CEOs is a feature of all political life, history and cultures.
The political timing of Finland’s admission into NATO
It has been a few weeks since the world watched the proverbial ink of approval dry on Finland’s
How to manage the stress of making the right business decisions
It can be stressful when you have to make important decisions regarding your business. We all want to
Reclaiming Canada’s key service export: Tourism
Tourism is an increasingly dynamic sector of the global economy; pre-2019 tourism was a $1.4 trillion industry generating
Takeda Supports Crohn’s and Colitis Canada PACE Network with $500,000 contribution
Takeda Canada Inc. announced its support for the Promoting Access and Care through Centres of Excellence (PACE) network and will be contributing $125,000 per year over four years, for a total of $500,000.
The Crohn’s and Colitis Canada PACE network is a unique charity-pharmaceutical industry collaboration that aims to improve quality of life for patients living with Crohn’s disease and ulcerative colitis – the two main forms of inflammatory bowel disease (IBD) – through the establishment of a national network of IBD Centres of Excellence.
“PACE brings together world-class patient care and research centres to advance the standard of care for Canadians living with Crohn’s disease and ulcerative colitis,” said Mina Mawani, President and CEO of Crohn’s and Colitis Canada. “Support from Takeda Canada and other industry partners is essential to the success of initiatives like PACE for the benefit of patients living with chronic diseases.”
Today’s announcement coincides with launch events at several of the IBD centres of excellence participating in the PACE network: Mount Sinai Hospital, McMaster University, and McGill University including research leads in each centre, pharmaceutical industry representatives, patients, and government dignitaries.
“Takeda Canada places great importance on its work in gastroenterology and IBD in particular. We recognize the challenges that people living with IBD face on a daily basis which is why we strive to help meet the needs of Canadian patients in as many ways as we can,” said Chatrick Paul, General Manager, Takeda Canada Inc. “It was clear to us that we needed to be involved in PACE because it identified crucial gaps in patient care and proposed very concrete plans to fill them. We are very pleased to support this network and look forward to seeing the results.”
Takeda Canada is a strong supporter of Crohn’s disease and ulcerative colitis research in Canada. The company’s support of the PACE network is the second major investment this year. Takeda recently invested $2.1 million in the Strategy for Patient-Oriented Research (SPOR) patient-centred gastrointestinal research initiative, IMAGINE, led by McMaster University.
- Read the current edition
- Recent posts
